Jennison Associates
CRNX icon

Jennison Associates’s Crinetics Pharmaceuticals CRNX Stock Holding History

Jennison Associates’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.9M Sell
904,672
-376,929
-29% -$16.8M 0.02% 273
2025
Q4 		$59.7M Sell
1,281,601
-763,133
-37% -$34M 0.04% 182
2025
Q3 		$85.2M Buy
2,044,734
+57,616
+3% +$1.84M 0.05% 149
2025
Q2 		$57.1M Sell
1,987,118
-132,649
-6% -$4.1M 0.03% 201
2025
Q1 		$71.1M Sell
2,119,767
-588,584
-22% -$22M 0.05% 161
2024
Q4 		$138M Sell
2,708,351
-85,263
-3% -$4.77M 0.08% 106
2024
Q3 		$143M Buy
2,793,614
+13,470
+0.5% +$695K 0.09% 94
2024
Q2 		$125M Sell
2,780,144
-37,710
-1% -$1.74M 0.08% 98
2024
Q1 		$132M Buy
2,817,854
+270,171
+11% +$10.6M 0.09% 94
2023
Q4 		$90.6M Buy
2,547,683
+1,113,992
+78% +$34.2M 0.07% 124
2023
Q3 		$42.6M Buy
1,433,691
+972,194
+211% +$20M 0.04% 196
2023
Q2 		$8.32M Buy
+461,497
New +$9.2M 0.01% 391

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return